EP Global Communications Inc fka EPGL

[H8ster]

Regardless of what anybody thinks of the FDA significance, the MPDD is approved. And it is good.

There are numerous trans-cutaneous electroneural stimulation (TENS) portable devices available in the marketplace. However, the leads (i.e., the electrodes) of these devices are designed for static and therapeutic purposes, rather than dynamic diagnosis purposes.

As a result, all those TENS devices are not appropriate for locating myofascial trigger points. The MPDD is.

Until now, there is no current device that effectively locates a myofascial trigger point. As a result, this has contributed to ignoring muscles as a major cause of most common pain problems and, unfortunately, has led to unnecessary testing, injections and medications, and surgeries.

Accordingly, there is a need for a device that can accurately diagnose and locate trigger points, which is portable and ergonomically designed....which is EPGL's, FDA approved and patented, MPDD.